Moxibustion for pre & stage 1 hypertension: a pilot randomized controlled open trial

Korea Institute of Oriental Medicine0 个研究点目标入组 40 人开始时间: 待定最近更新: 2019年3月11日

适应症

试验速览

暂无简介。

•1. patient age between 19 and 65 years
•2. Prehypertension or stage 1 hypertension (SBP 120 to 159, DBP: 80 to 99) according to JNC7 criteria
•3. Patients who give written, informed consent

•1. Patients who take prescription or OTC medication or herb/supplement for controlling blood pressure
•2. Secondary blood pressure patients
•3. Cerebrovascular or cardiovascular disease history
•4. Malignant cancer history
•5. Diabetes patients who currently need insulin injection or diabetic medications
•6. Several disease history: renal diseases, hepatic diseases, thyroid diseases, active Tbc and other infectious diseases
•7. Hemorrhagic diseases or patients who take anti-coagulants (except aspirin)
•8. Patients who have T-needle allergy
•9. Local infection at ear
•10. Participants who have systemic steroid therapy or immune depressants
•12. Participants who take medications which may affect blood pressure such as oral anticeptives, central nervous system depressants or stimulants
•13. Pregnant or breast-feeding women or women who have plan to be pregnant
•14. Participants who used traditional Korean medicinal treatment during last 1 months
•15. Participants who are unappropriate to this trial due to other reasons, decided by researchers

发起方